Tibet Financial Statements From 2010 to 2025

TBET Stock  USD 0.0001  0.00  0.00%   
Analyzing historical trends in various income statement and balance sheet accounts from Tibet Pharmaceuticals' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Tibet Pharmaceuticals' valuation are summarized below:
Gross Profit
14.2 M
Profit Margin
0.3179
Market Capitalization
1.5 K
Revenue
34.1 M
Earnings Share
0.01
There are currently one hundred nine fundamental trend indicators for Tibet Pharmaceuticals that can be evaluated and compared over time across competition. All traders should double-check Tibet Pharmaceuticals' current fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to 9.35 in 2025. Enterprise Value is likely to gain to about (8.3 M) in 2025

Tibet Pharmaceuticals Total Revenue

26.02 Million

Check Tibet Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tibet Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 2.5 M or Total Revenue of 26 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 488.7 K or PTB Ratio of 0.0. Tibet financial statements analysis is a perfect complement when working with Tibet Pharmaceuticals Valuation or Volatility modules.
  
Build AI portfolio with Tibet Stock
Check out the analysis of Tibet Pharmaceuticals Correlation against competitors.
For more information on how to buy Tibet Stock please use our How to Invest in Tibet Pharmaceuticals guide.

Tibet Pharmaceuticals Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets22.8 M32.4 M27.4 M
Slightly volatile
Other Current Liabilities850.4 K1.5 M1.2 M
Pretty Stable
Total Current LiabilitiesM5.4 M4.6 M
Slightly volatile
Total Stockholder Equity16.2 M27 M22.4 M
Pretty Stable
Net Tangible Assets15.3 M26.3 M21.8 M
Pretty Stable
Retained Earnings16.5 M15.7 M13.2 M
Slightly volatile
Accounts Payable2.6 M3.3 M2.8 M
Slightly volatile
Cash5.3 M8.7 M7.2 M
Pretty Stable
Other Assets353.4 K271.8 K321 K
Slightly volatile
Long Term Debt3.9 M4.1 M3.6 M
Slightly volatile
Net Receivables7.4 M14.2 M11.6 M
Pretty Stable
InventoryM1.1 M1.2 M
Slightly volatile
Other Current Assets61 K113.7 K92 K
Pretty Stable
Total Liabilities4.8 M4.2 M4.8 M
Slightly volatile
Short and Long Term Debt3.9 M4.1 M3.6 M
Slightly volatile
Total Current Assets14.1 M24.3 M20 M
Pretty Stable
Short Term Debt3.9 M4.1 M3.6 M
Slightly volatile
Intangible Assets615.3 K540.4 K619 K
Slightly volatile
Common Stock12.9 K13.6 K12 K
Slightly volatile
Property Plant Equipment5.3 M5.5 M6.1 M
Slightly volatile
Short Term Investments79.1 K89 K97 K
Slightly volatile

Tibet Pharmaceuticals Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative2.5 M3.3 M2.8 M
Slightly volatile
Total Revenue26 M37.2 M31.2 M
Slightly volatile
Gross Profit13.1 M18.6 M15.6 M
Slightly volatile
Operating Income10.6 M15.3 M12.8 M
Slightly volatile
Net Income From Continuing Ops10.4 M15.1 M12.6 M
Slightly volatile
EBIT10.6 M15.3 M12.8 M
Slightly volatile
Cost Of Revenue13 M18.6 M15.6 M
Slightly volatile
Total Operating Expenses15.4 M21.9 M18.4 M
Slightly volatile
Income Before Tax10.4 M15.1 M12.6 M
Slightly volatile
Net Income Applicable To Common Shares10.4 M15.1 M12.6 M
Slightly volatile
Net Income10.4 M15.1 M12.6 M
Slightly volatile
Research Development676.5 K710.7 K627.1 K
Slightly volatile

Tibet Pharmaceuticals Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Change In Cash2.3 MM3.3 M
Pretty Stable
Depreciation943.5 KM905.1 K
Slightly volatile
Dividends Paid4.1 M2.3 M2.7 M
Very volatile
Capital Expenditures251.3 K135.1 K186.2 K
Slightly volatile
Total Cash From Operating Activities8.9 MM7.9 M
Slightly volatile
Change To Operating Activities1.2 M1.2 M970.1 K
Slightly volatile
Net Income10.4 M15.1 M12.6 M
Slightly volatile
Change To Netincome7.9 K8.3 K18.3 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Dividend Yield488.7 K244.7 K241.6 K
Pretty Stable
PTB Ratio0.00.00.0
Pretty Stable
Days Sales Outstanding76.33125130
Very volatile
Book Value Per Share1.01.791.8446
Very volatile
Free Cash Flow Yield537.9 K587.2 K630.2 K
Very volatile
Operating Cash Flow Per Share0.560.60.6461
Very volatile
Average PayablesM2.6 M2.7 M
Pretty Stable
Stock Based Compensation To Revenue0.00550.00620.0067
Slightly volatile
Capex To Depreciation0.180.190.2094
Slightly volatile
PB Ratio0.00.00.0
Pretty Stable
Free Cash Flow Per Share0.540.590.6305
Very volatile
Inventory Turnover7.3912.1712.5571
Very volatile
Net Income Per Share0.651.01.0395
Very volatile
Days Of Inventory On Hand49.5231.0431.0829
Pretty Stable
Payables Turnover3.945.065.4574
Slightly volatile
Average InventoryM1.1 M1.2 M
Slightly volatile
Capex To Revenue0.00510.00530.007
Slightly volatile
Cash Per Share0.330.580.5931
Very volatile
POCF Ratio0.00.00.0
Slightly volatile
Interest Coverage41.6563.8966.4168
Very volatile
Payout Ratio0.210.220.2269
Slightly volatile
Capex To Operating Cash Flow0.02090.0220.0247
Slightly volatile
PFCF Ratio0.00.00.0
Pretty Stable
Days Payables Outstanding83.1274.6166.9742
Slightly volatile
Income Quality1.010.690.6569
Very volatile
ROE0.750.640.5784
Slightly volatile
PE Ratio0.00.00.0
Slightly volatile
Return On Tangible Assets0.380.430.4622
Pretty Stable
Earnings Yield644.8 KMM
Very volatile
Intangibles To Total Assets0.0450.02450.0253
Pretty Stable
Current Ratio2.734.034.2562
Pretty Stable
Tangible Book Value Per Share0.951.741.792
Very volatile
Receivables Turnover4.613.012.9212
Very volatile
Graham Number3.796.356.5658
Very volatile
Shareholders Equity Per Share1.01.791.8446
Very volatile
Debt To Equity0.390.33990.3471
Slightly volatile
Capex Per Share0.01390.01460.0156
Slightly volatile
Average ReceivablesM7.7 MM
Very volatile
Revenue Per Share1.622.472.5669
Very volatile
Interest Debt Per Share0.01740.01830.0353
Slightly volatile
Debt To Assets0.230.19950.2048
Slightly volatile
Price Earnings Ratio0.00.00.0
Slightly volatile
Operating Cycle112150160
Slightly volatile
Price Book Value Ratio0.00.00.0
Pretty Stable
Days Of Payables Outstanding83.1274.6166.9742
Slightly volatile
Dividend Payout Ratio0.210.220.2269
Slightly volatile
Price To Operating Cash Flows Ratio0.00.00.0
Slightly volatile
Price To Free Cash Flows Ratio0.00.00.0
Pretty Stable
Operating Profit Margin0.320.370.4018
Slightly volatile
Company Equity Multiplier1.651.381.2642
Pretty Stable
Long Term Debt To Capitalization0.290.25370.2587
Slightly volatile
Total Debt To Capitalization0.290.25370.2587
Slightly volatile
Return On Capital Employed0.450.510.5486
Pretty Stable
Debt Equity Ratio0.390.33990.3471
Slightly volatile
Ebit Per Revenue0.320.370.4018
Slightly volatile
Quick Ratio2.413.83.9777
Very volatile
Dividend Paid And Capex Coverage Ratio1.442.652.7309
Very volatile
Cash Ratio1.021.451.5329
Pretty Stable
Cash Conversion Cycle51.991.2695.5673
Pretty Stable
Operating Cash Flow Sales Ratio0.40.280.2644
Very volatile
Days Of Inventory Outstanding49.5231.0431.0829
Pretty Stable
Days Of Sales Outstanding76.33125130
Very volatile
Free Cash Flow Operating Cash Flow Ratio0.750.880.9549
Slightly volatile
Cash Flow Coverage Ratios1.852.62.7296
Very volatile
Price To Book Ratio0.00.00.0
Pretty Stable
Fixed Asset Turnover2.914.724.8761
Very volatile
Capital Expenditure Coverage Ratio24.7847.0847.5954
Very volatile
Price Cash Flow Ratio0.00.00.0
Slightly volatile
Debt Ratio0.230.19950.2048
Slightly volatile
Cash Flow To Debt Ratio1.852.62.7296
Very volatile
Return On Assets0.360.420.4507
Pretty Stable
Asset Turnover0.91.031.1142
Pretty Stable
Net Profit Margin0.320.370.3968
Slightly volatile
Gross Profit Margin0.40.450.4902
Slightly volatile
Price Fair Value0.00.00.0
Pretty Stable
Return On Equity0.750.640.5784
Slightly volatile

Tibet Pharmaceuticals Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap9.3510.6211.5669
Slightly volatile

About Tibet Pharmaceuticals Financial Statements

Tibet Pharmaceuticals shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Tibet Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Tibet Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Tibet Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue37.2 M26 M
Cost Of Revenue18.6 M13 M
Stock Based Compensation To Revenue 0.01  0.01 
Capex To Revenue 0.01  0.01 
Revenue Per Share 2.47  1.62 
Ebit Per Revenue 0.37  0.32 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Tibet Stock Analysis

When running Tibet Pharmaceuticals' price analysis, check to measure Tibet Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tibet Pharmaceuticals is operating at the current time. Most of Tibet Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tibet Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tibet Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tibet Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.